Good Lifestyle

Unlike cold medication orpainkiller You can buy over -the -counter (OTC) at the pharmacy, prescription drugs require the signature of your doctor before you can fill them. By doing this, you get an additional level of security by ensuring that you do not react negatively to the drug while keeping an eye on side effects or potentially dangerous interactions with other drugs. But now the Food & Drug Administration (FDA) warns patients who take common medication that they should call their doctor immediately. Read the rest to see which prescription could present a potential health risk.

Read this then:If you have one of these Colgate toothpaste, get rid of it, the FDA warns.

The drugs are under rigorous approval process before being able to head to pharmacies, then in your office, whether it is a prescription or an over -the -counter patent. However, reminders are sometimes necessary to ensure public security when officials discover that they can present any type of potential risk. In such a recent incident in September, the FDA announced that New JerseyEugia US LLC had published a voluntary reminder for its batch of ACYCLOVIR ACCYCLOVIVE SODIUM AND 10 ml (50 mg / ml), 10 ml of single dose bottle, which is also known by theZovirax brand name. The company said it fired the medication after receiving a complaint that noted "the presence of red, brown and black particles inside the bottle".

This same week, the FDA announced another reminder affectingWonder Pill Food Supplements Produced by the right trade LLC my stellar lifestyle. The agency said that the pills - which have been marketed for use in male sexual improvement andSold online by Walmart On its website - “serious health risks” for some people with underlying health problems because they were tainted with Tadalafil. More specifically, the ingredient could potentially interact with other prescription drugs such as nitroglycerin, leading to a drop in "potentially fatal" blood pressure.

And on September 29, the FDA announced that Golden State Medical Supply, Incorporated (GSMS, Inc.) had published a voluntary reminder for two of its prescription drugs,Clopidogrel tablets 75 mg and ATENOLOL tablets 25 mg. In this case, the company said itdrawn the products "By an abundance of prudence" after receiving a report according to which a bottle containing clopidogrel tablets 75 mg was poorly labeled as a tablet of ATENOLOL 25 mg, which could cause serious health problems due to the dosage incorrect.

But now the agency has issued another warning that affects a prescription drug.

On October 24, the FDA announced that New JerseyAurobindo Pharma USA, Inc. had published a voluntary reminder on two specific lots of its tablets of Quinapril and Hydrochlorothiazide USP 20mg / 12.5 mg. The affected products were sent for the first time by the company in May 2021 to customers in the country.AE0FCC31AE342FD3A1346EBB1F342FCB

The pills that are part of the recall are packed in plastic bottles stamped with the batch numbers QE2021005-A or QE2021010-A and have an expiration date of 01/2023. Depending on the agency's opinion, the tablets are "pink, marked, in the shape of a round, biconvex, tablets coated with films, dislocated with 'on the marked side and' 19'on other side." The FDA says that the tablets of Quinapril and Hydrochlorothiazide are prescribed "for the treatment of hypertension, to lower blood pressure".

RELATED:For more up-to-date information, register for our daily newsletter.

The company claims to have published the recall after discovering that the pills contained the impurity linked to the drug substance (NDSRI), N-Nitroso-Quinapril. Depending on the agency's reminder notice, nitrosamines are also commonly found in water and foods such as "cured and grilled meats, dairy products and vegetables" at lower levels. However, the FDA warns that impurity could increase the risk of cancer in people exposed to higher levels over a more prolonged period of time.

The FDA reports that so far there has been no report of unfavorable medical events linked to the affected article. However, the agency says that anyone who has the pills recalled should immediately call their doctor or health care provider to determine if they have to continue to take the medication or "consider alternative treatment before returning their drugs".

According to the agency's opinion, Quadnex will take care of the recall on behalf of Aurobindo Pharma USA. The company says it will contact distributors and certain customers by telephone and in writing so that they can start asking all the accounts concerned to return the drugs.

The FDA advises anyone who thinks he has experienced adverse effects following the product of the product should call her doctor immediately. Anyone with other questions or concerns about the recall of the quinapril and hydrochlorothiazide can also reach Quanalelex by calling the hotline or by contacting the e-mail address indicated on the recall notice.